BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 26443930)

  • 1. Stem cell therapy for cardiac regeneration: hits and misses.
    Padda J; Sequiera GL; Sareen N; Dhingra S
    Can J Physiol Pharmacol; 2015 Oct; 93(10):835-41. PubMed ID: 26443930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
    Sadahiro T; Yamanaka S; Ieda M
    Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy.
    Panda A; Gurusamy N; Rajasingh S; Carter HK; Thomas EL; Rajasingh J
    Differentiation; 2020; 112():58-66. PubMed ID: 31954271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming.
    Yamakawa H; Ieda M
    Int Heart J; 2015; 56(1):1-5. PubMed ID: 25742939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming.
    Budniatzky I; Gepstein L
    Stem Cells Transl Med; 2014 Apr; 3(4):448-57. PubMed ID: 24591731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells.
    Duran AG; Reidell O; Stachelscheid H; Klose K; Gossen M; Falk V; Röll W; Stamm C
    Thorac Cardiovasc Surg; 2018 Jan; 66(1):53-62. PubMed ID: 29216651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pluripotent reprogramming and lineage reprogramming: promises and challenges in cardiovascular regeneration.
    He WJ; Hou Q; Han QW; Han WD; Fu XB
    Tissue Eng Part B Rev; 2014 Aug; 20(4):304-13. PubMed ID: 24063625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of human cardiomyocytes for cardiac regenerative therapies: differentiation and direct reprogramming.
    Hodonsky C; Wu K; Mundada L; Si MS
    Curr Pharm Des; 2014; 20(12):2012-22. PubMed ID: 23844731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovation in basic science: stem cells and their role in the treatment of paediatric cardiac failure--opportunities and challenges.
    Kaushal S; Jacobs JP; Gossett JG; Steele A; Steele P; Davis CR; Pahl E; Vijayan K; Asante-Korang A; Boucek RJ; Backer CL; Wold LE
    Cardiol Young; 2009 Nov; 19 Suppl 2():74-84. PubMed ID: 19857353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Progress Using Pluripotent Stem Cells for Cardiac Regenerative Therapy.
    Ichimura H; Shiba Y
    Circ J; 2017 Jun; 81(7):929-935. PubMed ID: 28603177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced regeneration--the progress and promise of direct reprogramming for heart repair.
    Addis RC; Epstein JA
    Nat Med; 2013 Jul; 19(7):829-36. PubMed ID: 23836233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safe and Effective Cardiac Regenerative Therapy With Human-Induced Pluripotent Stem Cells: How Should We Prepare Pure Cardiac Myocytes?
    Tohyama S; Fukuda K
    Circ Res; 2017 May; 120(10):1558-1560. PubMed ID: 28495993
    [No Abstract]   [Full Text] [Related]  

  • 13. Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications.
    Abdelwahid E; Siminiak T; Guarita-Souza LC; Teixeira de Carvalho KA; Gallo P; Shim W; Condorelli G
    Curr Cardiol Rev; 2011 Aug; 7(3):201-12. PubMed ID: 22758618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Another possible cell source for cardiac regenerative medicine: reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells.
    Xie X; Sun A; Huang Z; Zhu W; Wang S; Zou Y; Ge J
    Med Hypotheses; 2011 Mar; 76(3):365-7. PubMed ID: 21087827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise.
    Duelen R; Sampaolesi M
    EBioMedicine; 2017 Feb; 16():30-40. PubMed ID: 28169191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.
    Yoshida Y; Yamanaka S
    Circ Res; 2017 Jun; 120(12):1958-1968. PubMed ID: 28596174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human embryonic stem cells vs human induced pluripotent stem cells for cardiac repair.
    Barad L; Schick R; Zeevi-Levin N; Itskovitz-Eldor J; Binah O
    Can J Cardiol; 2014 Nov; 30(11):1279-87. PubMed ID: 25442431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Strategies for Cardiac Diseases: Lineage Reprogramming of Somatic Cells into Induced Cardiomyocytes.
    Wang M; Ling W; Xiong C; Xie D; Chu X; Li Y; Qiu X; Li Y; Xiao X
    Cell Reprogram; 2019 Apr; 21(2):63-77. PubMed ID: 30907633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells and the treatment of cardiac disease.
    Minguell JJ; Erices A
    Exp Biol Med (Maywood); 2006 Jan; 231(1):39-49. PubMed ID: 16380643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA and Cardiac Regeneration.
    Gnecchi M; Pisano F; Bariani R
    Adv Exp Med Biol; 2015; 887():119-41. PubMed ID: 26662989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.